Notice: Undefined offset: 1 in /var/www/jopcr.com/article-detail-page.php on line 103
Bridging the Knowledge Gap: Educating Novice Nurses on Pharmacovigilance
 
  • P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Bridging the Knowledge Gap: Educating Novice Nurses on Pharmacovigilance
  • VIEWS 7
  • PDF 2

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v24.i2.43

Year: 2025, Volume: 24, Issue: 2, Pages: 110–117

Original Article

Bridging the Knowledge Gap: Educating Novice Nurses on Pharmacovigilance

Mpho Z Shelile1,∗, Rasemoko R Polile2

1M.Sc. in Nursing (NWU), Faculty of Health Sciences, National University of Lesotho, Lesotho
2M.Sc. in Pharmacology (NWU), Faculty of Health Sciences, National University of Lesotho, Lesotho

*Corresponding Author
Email: mz.shelile@nul.ls

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Pharmacovigilance plays a crucial role in assessing the risk-benefit ratio of medications, promoting their safe, rational, and effective use, and ultimately improving patient safety and care. Nurses play a fundamental role in drug administration and monitoring the therapeutic and non-therapeutic effects of drugs. The study aimed to assess knowledge, attitudes, and practices regarding pharmacovigilance among newly graduated registered nurses in Lesotho, both before and after an educational intervention. This study utilized a questionnaire-based educational intervention with a pre- and post-test design, involving newly graduated registered nurses. A link to a 15-item pre-validated electronic questionnaire assessing knowledge, attitudes, and practices related to pharmacovigilance was distributed to newly graduated registered nurses before and after an educational intervention. Ethical clearance and consent from the respondents were secured prior to the start of the study. A total of 197 newly graduated registered nurses from 6 nurse training institutions participated in this pre- and post-KAP questionnaire study. When comparing the KAP of pharmacovigilance before and after the educational intervention, the increase in correct response rates was statistically significant (P < 0.001). The training evaluation received positive feedback from the participants. Incorporating a pharmacovigilance module into pre-service nurse training is essential. Additionally, continuing in-service and hands-on nurse training on adverse drug reaction reporting can enhance the KAP of pharmacovigilance and improve adverse drug reaction reporting in nursing practice. The concepts of pharmacovigilance and adverse drug reaction reporting should be further reinforced, as there is significant potential for growth in this area.

Keywords: Adverse drug reaction, Novice nurse, Pharmacovigilance, Reporting

References

  1. The importance of pharmacovigilance-safety monitoring of medicinal products. United Kingdom. World Health Organization. 2002.
  2. Ali MD, Hassan YA, Ahmad A, Alaqel O, Al-Harbi H, Al-Suhaimi NM. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Current Drug Safety. 2018;13(1):21–25. Available from: https://dx.doi.org/10.2174/1574886313666171218123802
  3. Nimesh S, Chaudhary A, Sharma A, Dev K. Pharmacovigilance programme of India: a review. Acta Scientific Pharmaceutical Sciences. 2019;3(9):12–17. Available from: https://actascientific.com/ASPS/pdf/ASPS-03-0364.pdf
  4. Tripathi KD. Essentials of Medical Pharmacology (8). (p. 1080 pages) Jaypee Brothers Medical Publishers (P) Ltd.. 2018.
  5. Bouvy JC, Bruin MLD, Koopmanschap MA. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Drug Safety. 2015;38(5):437–453. Available from: https://dx.doi.org/10.1007/s40264-015-0281-0
  6. Ferner R. Adverse Drug Reactions. Medicine. 2003;31(8):20–24. Available from: https://dx.doi.org/10.1383/medc.31.8.20.27683
  7. Campbell J, Gossell-Williams M, Lee M. A Review of Pharmacovigilance. West Indian Medical Journal. 2015;63:771–774. Available from: https://dx.doi.org/10.7727/wimj.2013.251
  9. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19. Available from: https://dx.doi.org/10.1136/bmj.329.7456.15
  11. Kim HJJ, Jeong HE, Bae JHH, Baek YHH, Shin JYY. Characteristics and trends of spontaneous reporting of therapeutic ineffectiveness in South Korea from 2000 to 2016. PLOS ONE. 2000;14(2):1–14. Available from: https://doi.org/10.1371/journal.pone.0212905
  12. Ampadu HH, Hoekman J, Arhinful D, Amoama-Dapaah M, Leufkens HGM, Dodoo ANO. Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences. Globalization and Health. 2018;14(1):1–17. Available from: https://dx.doi.org/10.1186/s12992-018-0431-0
  13. Babigumira JB, Stergachis A, Choi HL, Dodoo A, Nwokike J, Garrison LP. A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries. Drug Safety. 2014;37(3):127–134. Available from: https://dx.doi.org/10.1007/s40264-014-0143-1
  14. Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Review of Clinical Pharmacology. 2015;8(4):449–460. Available from: https://dx.doi.org/10.1586/17512433.2015.1053391
  15. Barry A, Olsson S, Minzi O, Bienvenu E, Makonnen E, Kamuhabwa A, et al. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania. Drug Safety. 2020;43(4):339–350. Available from: https://dx.doi.org/10.1007/s40264-019-00898-z
  17. Ibrahim DM, Shawki MA, Solayman MH, Sabri NA. Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions? International Journal of Clinical Practice. 2021;75(11). Available from: https://dx.doi.org/10.1111/ijcp.14731
  18. Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. Journal of Clinical Epidemiology. 2002;55(9):945–950. Available from: https://dx.doi.org/10.1016/s0895-4356(02)00450-x
  19. Perlik F, Slanar O, Smid M, Petracek J. Attitude of Czech physicians to adverse drug reaction reporting. European Journal of Clinical Pharmacology. 2002;58(5):367–369. Available from: https://doi.org/10.1007/s00228-002-0476-z
  20. Adhikari A, Indu R, Ray M, Bhattacharya S, Biswas R, Das AK. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacovigilance study. International Journal of Advances in Medicine. 2017;4(6):1685–1689. Available from: https://dx.doi.org/10.18203/2349-3933.ijam20175191
  21. Lambrini K, Kotsiftopoulos CH, Papageorgiou M, CHI, AM. The Rational Use of Antibiotics Medicine. Journal of Healthcare Communications. 2017;2(03):1–4. Available from: https://doi.org/10.4172/2472-1654.100076
  23. Jeetu G, Anusha G. Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring. Journal of Young Pharmacists. 2010;2(3):315–320. Available from: https://dx.doi.org/10.4103/0975-1483.66802
  28. Prasanth A, Panhathodi R, George A. Rae Joyce (Rachel Fenton) interview. Journal of Graphic Novels and Comics. 2021;12:1224–1235 . Available from: https://dx.doi.org/10.1080/21504857.2020.1802317
  29. Suveges LG, Gesy KF, Wallace SM, Blackburn JL, Appel WC. Adverse Drug Reaction Reporting Part II: Evaluation of the Saskatchewan Pilot Project for a Regional Reporting Program in Canada. Drug Information Journal. 1995;29(2):581–589. Available from: https://dx.doi.org/10.1177/009286159502900233
  31. Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey. Drug Safety. 2016;39(12):1239–1250. Available from: https://dx.doi.org/10.1007/s40264-016-0465-2
  32. Newton PN, Bond KC, et al. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. The Lancet Global Health. 2020;8(6):e754–e755. Available from: https://dx.doi.org/10.1016/s2214-109x(20)30136-4
  33. Ekman E, Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. European Journal of Clinical Pharmacology. 2009;65(1):43–46. Available from: https://dx.doi.org/10.1007/s00228-008-0564-9
  34. Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chinese Medical Journal. 2004;117(6):856–861. Available from: https://pubmed.ncbi.nlm.nih.gov/15198887/
  35. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology. 2009;9(1):1–8. Available from: https://dx.doi.org/10.1186/1472-6904-9-14
  36. Bäckström M, Mjörndal T, Dahlqvist R, Nordkvist-Olsson T. Attitudes to reporting adverse drug reactions in northern Sweden. European Journal of Clinical Pharmacology. 2000;56(9-10):729–732. Available from: https://dx.doi.org/10.1007/s002280000202

Copyright

© 2025 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 24 July 2025

Year: 2025, Volume: 24, Issue: 2


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.